Case Study in Neonatology

Chapter

Abstract

Neonatology represents per se a challenging clinical setting, where decision-making faces multifaceted issues and where the conduct of high-quality and large randomised trials is not easy. Umbrella reviews, overviews of reviews and meta-epidemiologic studies offer an important and efficient set of tools to integrate the evidence base in this peculiar discipline, while pinpointing areas of uncertainty either because of poor precision in effect estimates or at risk of inaccuracy due to sources of bias.

Keywords

Neonatology Newborn Overview of reviews Paediatrics Umbrella review 

References

  1. 1.
    Bolisetty S, Legge N, Bajuk B, Lui K, New South W, the Australian Capital Territory Neonatal Intensive Care Units’ Data C. Preterm infant outcomes in New South Wales and the Australian capital territory. J Paediatr Child Health. 2015;51(7):713–21.CrossRefPubMedGoogle Scholar
  2. 2.
    Patel H, Beeby PJ, Henderson-Smart DJ. Predicting the need for ventilatory support in neonates 30–36 weeks’ gestational age. J Paediatr Child Health. 2003;39:206–9.CrossRefPubMedGoogle Scholar
  3. 3.
    Melamed N, Klinger G, Tenenbaum-Gavish K, Herscovici T, Linder N, Hod M, Yogev Y. Short-term neonatal outcome in low-risk, spontaneous, singleton, late preterm deliveries. Obstet Gynecol. 2009;114:253–60.CrossRefPubMedGoogle Scholar
  4. 4.
    Yoder BA, Gordon MC, Barth Jr WH. Late-preterm birth: does the changing obstetric paradigm alter the epidemiology of respiratory complications? Obstet Gynecol. 2008;111:814–22.CrossRefPubMedGoogle Scholar
  5. 5.
    Ghartey K, Coletta J, Lizarraga L, Murphy E, Ananth CV, Gyamfi-Bannerman C. Neonatal respiratory morbidity in the early term delivery. Am J Obstet Gynecol. 2012;207:292.e1–4.CrossRefGoogle Scholar
  6. 6.
    Hansen AK, Wisborg K, Uldbjerg N, Henriksen TB. Risk of respiratory morbidity in term infants delivered by elective caesarean section: cohort study. BMJ. 2008;336:85–7.PubMedCentralCrossRefPubMedGoogle Scholar
  7. 7.
    Tita AT, Landon MB, Spong CY, Lai Y, Leveno KJ, Varner MW, Moawad AH, Caritis SN, Meis PJ, Wapner RJ, Sorokin Y, Miodovnik M, Carpenter M, Peaceman AM, O’Sullivan MJ, Sibai BM, Langer O, Thorp JM, Ramin SM, Mercer BM, Eunice Kennedy Shriver NM-FMUN. Timing of elective repeat cesarean delivery at term and neonatal outcomes. N Engl J Med. 2009;360:111–20.PubMedCentralCrossRefPubMedGoogle Scholar
  8. 8.
    Cheng YW, Nicholson JM, Nakagawa S, Bruckner TA, Washington AE, Caughey AB. Perinatal outcomes in low-risk term pregnancies: do they differ by week of gestation? Am J Obstet Gynecol. 2008;199:370.e1–7.CrossRefGoogle Scholar
  9. 9.
    Hansen AK, Wisborg K, Uldbjerg N, Henriksen TB. Elective caesarean section and respiratory morbidity in the term and near-term neonate. Acta Obstet Gynecol Scand. 2007;86:389–94.CrossRefPubMedGoogle Scholar
  10. 10.
    Doyle LW, Bowman E, Davis P, Halliday J. Preterm infants 30–36 weeks’ gestation in Victoria--where should they be delivered? Aust N Z J Obstet Gynaecol. 1998;38:298–300.CrossRefPubMedGoogle Scholar
  11. 11.
    Dunn PM. The respiratory distress syndrome of the newborn: immaturity versus prematurity. Arch Dis Child. 1965;40:62–5.PubMedCentralCrossRefPubMedGoogle Scholar
  12. 12.
    Usher RH, Allen AC, McLean FH. Risk of respiratory distress syndrome related to gestational age, route of delivery, and maternal diabetes. Am J Obstet Gynecol. 1971;111:826–32.PubMedGoogle Scholar
  13. 13.
    Lawn JE, Wilczynska-Ketende K, Cousens SN. Estimating the causes of 4 million neonatal deaths in the year 2000. Int J Epidemiol. 2006;35:706–18.CrossRefPubMedGoogle Scholar
  14. 14.
    Morrison JJ, Rennie JM, Milton PJ. Neonatal respiratory morbidity and mode of delivery at term: influence of timing of elective caesarean section. Br J Obstet Gynaecol. 1995;102:101–6.CrossRefPubMedGoogle Scholar
  15. 15.
    Bastek JA, Sammel MD, Pare E, Srinivas SK, Posencheg MA, Elovitz MA. Adverse neonatal outcomes: examining the risks between preterm, late preterm, and term infants. Am J Obstet Gynecol. 2008;199:367.e1–8.CrossRefGoogle Scholar
  16. 16.
    Parikh LI, Reddy UM, Mannisto T, Mendola P, Sjaarda L, Hinkle S, Chen Z, Lu Z, Laughon SK. Neonatal outcomes in early term birth. Am J Obstet Gynecol. 2014;211:265.e1–11.CrossRefGoogle Scholar
  17. 17.
    Bastek JA, Srinivas SK, Sammel MD, Elovitz MA. Do neonatal outcomes differ depending on the cause of preterm birth? A comparison between spontaneous birth and iatrogenic delivery for preeclampsia. Am J Perinatol. 2010;27:163–9.CrossRefPubMedGoogle Scholar
  18. 18.
    De Los Santos-Garate AM, Villa-Guillen M, Villanueva-Garcia D, Vallejos-Ruiz ML, Murguia-Peniche MT, Network NEs. Perinatal morbidity and mortality in late-term and post-term pregnancy. NEOSANO perinatal network’s experience in Mexico. J Perinatol. 2011;31:789–93.CrossRefPubMedGoogle Scholar
  19. 19.
    King JF, Flenady VJ, Papatsonis DN, Dekker GA, Carbonne B. Calcium channel blockers for inhibiting preterm labour. Cochrane Database Syst Rev. 2003;(1):CD002255.Google Scholar
  20. 20.
    Mackeen AD, Seibel-Seamon J, Grimes-Dennis J, Baxter JK, Berghella V. Tocolytics for preterm premature rupture of membranes. Cochrane Database Syst Rev. 2011;(10):CD007062.Google Scholar
  21. 21.
    Kenyon S, Boulvain M, Neilson JP. Antibiotics for preterm rupture of membranes. Cochrane Database Syst Rev. 2013;(12):CD001058.Google Scholar
  22. 22.
    Dodd JM, Jones L, Flenady V, Cincotta R, Crowther CA. Prenatal administration of progesterone for preventing preterm birth in women considered to be at risk of preterm birth. Cochrane Database Syst Rev. 2013;(7):CD004947.Google Scholar
  23. 23.
    Alfirevic Z, Stampalija T, Roberts D, Jorgensen AL. Cervical stitch (cerclage) for preventing preterm birth in singleton pregnancy. Cochrane Database Syst Rev. 2012;(4):CD008991.Google Scholar
  24. 24.
    Rafael TJ, Berghella V, Alfirevic Z. Cervical stitch (cerclage) for preventing preterm birth in multiple pregnancy. Cochrane Database Syst Rev. 2014;(9):CD009166.Google Scholar
  25. 25.
    Roberts D, Dalziel S. Antenatal corticosteroids for accelerating fetal lung maturation for women at risk of preterm birth. Cochrane Database Syst Rev. 2006;(3):CD004454.Google Scholar
  26. 26.
    Crowther CA, McKinlay CJ, Middleton P, Harding JE. Repeat doses of prenatal corticosteroids for women at risk of preterm birth for improving neonatal health outcomes. Cochrane Database Syst Rev. 2011;(6):CD003935.Google Scholar
  27. 27.
    Gulmezoglu AM, Crowther CA, Middleton P, Heatley E. Induction of labour for improving birth outcomes for women at or beyond term. Cochrane Database Syst Rev. 2012;(6):CD004945.Google Scholar
  28. 28.
    Antenatal Corticosteroid Clinical Practice Guidelines Panel. Antenatal corticosteroids given to women prior to birth to improve fetal, infant, child and adult health: clinical practice guidelines. Auckland: Liggins Institute, The University of Auckland; 2015.Google Scholar
  29. 29.
    Ahmed MR, Sayed Ahmed WA, Mohammed TY. Antenatal steroids at 37 weeks, does it reduce neonatal respiratory morbidity? A randomized trial. J Matern Fetal Neonatal Med. 2014;12:1486–90.Google Scholar
  30. 30.
    Stutchfield P, Whitaker R, Russell I, Antenatal Steroids for Term Elective Caesarean Section Research T. Antenatal betamethasone and incidence of neonatal respiratory distress after elective caesarean section: pragmatic randomised trial. BMJ. 2005;331:662.PubMedCentralCrossRefPubMedGoogle Scholar
  31. 31.
    Rosenstein MG, Cheng YW, Snowden JM, Nicholson JM, Caughey AB. Risk of stillbirth and infant death stratified by gestational age. Obstet Gynecol. 2012;120:76–82.PubMedCentralCrossRefPubMedGoogle Scholar
  32. 32.
    Henderson-Smart DJ, Wilkinson A, Raynes-Greenow CH. Mechanical ventilation for newborn infants with respiratory failure due to pulmonary disease. Cochrane Database Syst Rev. 2002;(4):CD002770.Google Scholar
  33. 33.
    Ho JJ, Subramaniam P, Henderson-Smart DJ, Davis PG. Continuous distending pressure for respiratory distress syndrome in preterm infants. Cochrane Database Syst Rev. 2002;(2);CD002271.Google Scholar
  34. 34.
    Ho JJ, Henderson-Smart DJ, Davis PG. Early versus delayed initiation of continuous distending pressure for respiratory distress syndrome in preterm infants. Cochrane Database Syst Rev. 2002;(2):CD002975.Google Scholar
  35. 35.
    Tang S, Zhao J, Shen J, Hu Z, Shi Y. Nasal intermittent positive pressure ventilation versus nasal continuous positive airway pressure in neonates: a systematic review and meta-analysis. Indian Pediatr. 2013;50:371–6.CrossRefPubMedGoogle Scholar
  36. 36.
    Abdel-Latif ME, Osborn DA. Laryngeal mask airway surfactant administration for prevention of morbidity and mortality in preterm infants with or at risk of respiratory distress syndrome. Cochrane Database Syst Rev. 2011;(7):CD008309.Google Scholar
  37. 37.
    Gopel W, Kribs A, Ziegler A, Laux R, Hoehn T, Wieg C, Siegel J, Avenarius S, von der Wense A, Vochem M, Groneck P, Weller U, Moller J, Hartel C, Haller S, Roth B, Herting E, Neonatal N. German. Avoidance of mechanical ventilation by surfactant treatment of spontaneously breathing preterm infants (AMV): an open-label, randomised, controlled trial. Lancet. 2011;378:1627–34.CrossRefPubMedGoogle Scholar
  38. 38.
    Kribs A, Roll C, Gopel W, Wieg C, Groneck P, Laux R, Teig N, Hoehn T, Bohm W, Welzing L, Vochem M, Hoppenz M, Buhrer C, Mehler K, Stutzer H, Franklin J, Stohr A, Herting E, Roth B, Investigators NT. Nonintubated surfactant application vs conventional therapy in extremely preterm infants: a randomized clinical trial. JAMA Pediatr. 2015;169(8):723–30.CrossRefPubMedGoogle Scholar
  39. 39.
    Kanmaz HG, Erdeve O, Canpolat FE, Mutlu B, Dilmen U. Surfactant administration via thin catheter during spontaneous breathing: randomized controlled trial. Pediatrics. 2013;131:e502–9.CrossRefPubMedGoogle Scholar
  40. 40.
    Heidarzadeh M, Mirnia K, Hoseini MB, Sadeghnia A, Akrami F, Balila M, Ghojazadeh M, Shafai F. Surfactant administration via thin catheter during spontaneous breathing: randomized controlled trial in alzahra hospital. Iran J Neonatology. 2013;4:5–9.Google Scholar
  41. 41.
    Mohammadizadeh M, Ardestani AG, Sadeghnia AR. Early administration of surfactant via a thin intratracheal catheter in preterm infants with respiratory distress syndrome: feasibility and outcome. J Res Pharm Pract. 2015;4:31–6.PubMedCentralCrossRefPubMedGoogle Scholar
  42. 42.
    Henderson-Smart DJ, Wilkinson A, Raynes-Greenow CH. Mechanical ventilation for newborn infants with respiratory failure due to pulmonary disease. Cochrane Database Syst Rev. 2002;(40):CD002770.Google Scholar
  43. 43.
    Rojas-Reyes MX, Morley CJ, Soll R. Prophylactic versus selective use of surfactant in preventing morbidity and mortality in preterm infants. Cochrane Database Syst Rev. 2012;(3):CD000510.Google Scholar
  44. 44.
    Dunn MS, Kaempf J, de Klerk A, de Klerk R, Reilly M, Howard D, Ferrelli K, O’Conor J, Soll RF. Vermont oxford network DRMSG. Randomized trial comparing 3 approaches to the initial respiratory management of preterm neonates. Pediatrics. 2011;128:e1069–76.CrossRefPubMedGoogle Scholar
  45. 45.
    Sandri F, Plavka R, Ancora G, Simeoni U, Stranak Z, Martinelli S, Mosca F, Nona J, Thomson M, Verder H, Fabbri L, Halliday H, Group CS. Prophylactic or early selective surfactant combined with nCPAP in very preterm infants. Pediatrics. 2010;125:e1402–9.CrossRefPubMedGoogle Scholar
  46. 46.
    Network SSGotEKSNNR, Finer NN, Carlo WA, Walsh MC, Rich W, Gantz MG, Laptook AR, Yoder BA, Faix RG, Das A, Poole WK, Donovan EF, Newman NS, Ambalavanan N, Frantz 3rd ID, Buchter S, Sanchez PJ, Kennedy KA, Laroia N, Poindexter BB, Cotten CM, Van Meurs KP, Duara S, Narendran V, Sood BG, O’Shea TM, Bell EF, Bhandari V, Watterberg KL, Higgins RD. Early CPAP versus surfactant in extremely preterm infants. N Engl J Med. 2010;362:1970–9.CrossRefGoogle Scholar
  47. 47.
    Bahadue FL, Soll R. Early versus delayed selective surfactant treatment for neonatal respiratory distress syndrome. Cochrane Database Syst Rev. 2012;(11):CD001456.Google Scholar
  48. 48.
    Stevens TP, Harrington EW, Blennow M, Soll RF. Early surfactant administration with brief ventilation vs. selective surfactant and continued mechanical ventilation for preterm infants with or at risk for respiratory distress syndrome. Cochrane Database Syst Rev. 2007;(4):CD003063.Google Scholar
  49. 49.
    Kendig JW, Ryan RM, Sinkin RA, Maniscalco WM, Notter RH, Guillet R, Cox C, Dweck HS, Horgan MJ, Reubens LJ, Risemberg H, Phelps DL. Comparison of two strategies for surfactant prophylaxis in very premature infants: a multicenter randomized trial. Pediatrics. 1998;101:1006–12.CrossRefPubMedGoogle Scholar
  50. 50.
    Soll R, Ozek E. Multiple versus single doses of exogenous surfactant for the prevention or treatment of neonatal respiratory distress syndrome. Cochrane Database Syst Rev. 2009;(1):CD000141.Google Scholar
  51. 51.
    El Shahed AI, Dargaville P, Ohlsson A, Soll RF. Surfactant for meconium aspiration syndrome in full term/near term infants. Cochrane Database Syst Rev. 2007;(3):CD002054.Google Scholar
  52. 52.
    Hahn S, Choi HJ, Soll R, Dargaville PA. Lung lavage for meconium aspiration syndrome in newborn infants. Cochrane Database Syst Rev. 2013;(4):CD003486.Google Scholar
  53. 53.
    Abdel-Latif ME, Osborn DA, Challis D. Intra-amniotic surfactant for women at risk of preterm birth for preventing respiratory distress in newborns. Cochrane Database Syst Rev. 2010;(1):CD007916.Google Scholar
  54. 54.
    Abdel-Latif ME, Osborn DA. Pharyngeal instillation of surfactant before the first breath for prevention of morbidity and mortality in preterm infants at risk of respiratory distress syndrome. Cochrane Database Syst Rev. 2011;(3):CD008311.Google Scholar
  55. 55.
    Abdel-Latif ME, Osborn DA. Nebulised surfactant in preterm infants with or at risk of respiratory distress syndrome. Cochrane Database Syst Rev. 2012;(10):CD008310.Google Scholar
  56. 56.
    Spence K, Barr P. Nasal versus oral intubation for mechanical ventilation of newborn infants. Cochrane Database Syst Rev. 2000;(2):CD000948.Google Scholar
  57. 57.
    Findlay RD, Taeusch HW, Walther FJ. Surfactant replacement therapy for meconium aspiration syndrome. Pediatrics. 1996;97:48–52.PubMedGoogle Scholar
  58. 58.
    Lotze A, Mitchell BR, Bulas DI, Zola EM, Shalwitz RA, Gunkel JH. Multicenter study of surfactant (Beractant) use in the treatment of term infants with severe respiratory failure. Survanta in term infants study group. J Pediatr. 1998;132:40–7.CrossRefPubMedGoogle Scholar
  59. 59.
    Ng E, Taddio A, Ohlsson A. Intravenous midazolam infusion for sedation of infants in the neonatal intensive care unit. Cochrane Database Syst Reviews. 2012;(6):CD002052.Google Scholar
  60. 60.
    Bellù R, de Waal KA, Zanini R. Opioids for neonates receiving mechanical ventilation. Cochrane Database Syst Rev. 2008;(1):CD004212.Google Scholar
  61. 61.
    Cools F, Offringa M. Neuromuscular paralysis for newborn infants receiving mechanical ventilation. Cochrane Database Syst Rev. 2005;(2):CD002773.Google Scholar
  62. 62.
    Kamlin C, Davis PG. Long versus short inspiratory times in neonates receiving mechanical ventilation. Cochrane Database Syst Rev. 2004;(4):CD004503.Google Scholar
  63. 63.
    Greenough A, Dimitriou G, Prendergast M, Milner AD. Synchronized mechanical ventilation for respiratory support in newborn infants. Cochrane Database Syst Rev. 2008;(1):CD000456.Google Scholar
  64. 64.
    Wheeler K, Klingenberg C, McCallion N, Morley CJ, Davis PG. Volume-targeted versus pressure-limited ventilation in the neonate. Cochrane Database Syst Rev. 2010;(11):CD003666.Google Scholar
  65. 65.
    Cools F, Henderson-Smart DJ, Offringa M, Askie LM. Elective high frequency oscillatory ventilation versus conventional ventilation for acute pulmonary dysfunction in preterm infants. Cochrane Database Syst Rev. 2009;(3):CD000104.Google Scholar
  66. 66.
    Henderson-Smart DJ, De Paoli AG, Clark RH, Bhuta T. High frequency oscillatory ventilation versus conventional ventilation for infants with severe pulmonary dysfunction born at or near term. Cochrane Database Syst Rev. 2009;(3):CD002974.Google Scholar
  67. 67.
    Barrington KJ, Finer N. Inhaled nitric oxide for respiratory failure in preterm infants. Cochrane Database Syst Rev. 2010;(12):CD000509.Google Scholar
  68. 68.
    Finer NN, Barrington KJ. Nitric oxide for respiratory failure in infants born at or near term. Cochrane Database Syst Rev. 2006;(4):CD000399.Google Scholar
  69. 69.
    Shah PS, Ohlsson A. Sildenafil for pulmonary hypertension in neonates. Cochrane Database Syst Rev. 2011;(8):CD005494.Google Scholar
  70. 70.
    Rojas MA, Lozano JM, Rojas MX, Bose CL, Rondon MA, Ruiz G, Pineros JG, Rojas C, Robayo G, Hoyos A, Celis LA, Torres S, Correa J, Columbian Neonatal Reseaerch N. Randomized, multicenter trial of conventional ventilation versus high-frequency oscillatory ventilation for the early management of respiratory failure in term or near-term infants in Colombia. J Perinatol. 2005;25:720–4.CrossRefPubMedGoogle Scholar
  71. 71.
    Clark RH, Yoder BA, Sell MS. Prospective, randomized comparison of high-frequency oscillation and conventional ventilation in candidates for extracorporeal membrane oxygenation. J Pediatr. 1994;124:447–54.CrossRefPubMedGoogle Scholar
  72. 72.
    Henderson-Smart DJ, Davis PG. Prophylactic methylxanthines for endotracheal extubation in preterm infants. Cochrane Database Syst Rev. 2010;(12):CD000139.Google Scholar
  73. 73.
    Davis PG, Henderson-Smart DJ. Extubation from low-rate intermittent positive airways pressure versus extubation after a trial of endotracheal continuous positive airways pressure in intubated preterm infants. Cochrane Database Syst Rev. 2001;(4):CD001078.Google Scholar
  74. 74.
    Davis PG, Henderson-Smart DJ. Nasal continuous positive airways pressure immediately after extubation for preventing morbidity in preterm infants. Cochrane Database Syst Rev. 2003;(2):CD000143.Google Scholar
  75. 75.
    Davis PG, Lemyre B, de Paoli AG. Nasal intermittent positive pressure ventilation (NIPPV) versus nasal continuous positive airway pressure (NCPAP) for preterm neonates after extubation. Cochrane Database Syst Rev. 2001;(2):CD003212.Google Scholar
  76. 76.
    De Paoli AG, Davis PG, Faber B, Morley CJ. Devices and pressure sources for administration of nasal continuous positive airway pressure (NCPAP) in preterm neonates. Cochrane Database Syst Rev. 2008;(1):CD002977.Google Scholar
  77. 77.
    Wilkinson D, Andersen C, O’Donnell CP, De Paoli AG. High flow nasal cannula for respiratory support in preterm infants. Cochrane Database Syst Rev. 2011;(5):CD006405.Google Scholar
  78. 78.
    Halliday HL, Ehrenkranz RA, Doyle LW. Early (<8 days) postnatal corticosteroids for preventing chronic lung disease in preterm infants. Cochrane Database Syst Rev. 2010;(1):CD001146.Google Scholar
  79. 79.
    Halliday HL, Ehrenkranz RA, Doyle LW. Late (>7 days) postnatal corticosteroids for chronic lung disease in preterm infants. Cochrane Database Syst Rev. 2009;(1):CD001145.Google Scholar
  80. 80.
    Davis PG, Henderson-Smart DJ. Intravenous dexamethasone for extubation of newborn infants. Cochrane Database Syst Rev. 2001;(4):CD000308.Google Scholar
  81. 81.
    Ward M, Sinn J. Steroid therapy for meconium aspiration syndrome in newborn infants. Cochrane Database Syst Rev. 2003;(4):CD003485.Google Scholar
  82. 82.
    Stewart A, Brion LP, Soll R. Diuretics for respiratory distress syndrome in preterm infants. Cochrane Database Syst Rev. 2011;(12):CD001454.Google Scholar
  83. 83.
    Stewart A, Brion LP, Ambrosio-Perez I. Diuretics acting on the distal renal tubule for preterm infants with (or developing) chronic lung disease. Cochrane Database Syst Rev. 2011;(9):CD001817.Google Scholar
  84. 84.
    Stewart A, Brion LP. Intravenous or enteral loop diuretics for preterm infants with (or developing) chronic lung disease. Cochrane Database Syst Rev. 2011;(9):CD001453.Google Scholar
  85. 85.
    Tan A, Schulze A, O’Donnell CP, Davis PG. Air versus oxygen for resuscitation of infants at birth. Cochrane Database Syst Rev. 2005;(2):CD002273.Google Scholar
  86. 86.
    Brown JV, Moe-Byrne T, Harden M, McGuire W. Lower versus higher oxygen concentration for delivery room stabilisation of preterm neonates: systematic review. PLoS One. 2012;7:e52033.PubMedCentralCrossRefPubMedGoogle Scholar
  87. 87.
    Group BIUKC, Group BIAC, Group BINZC, Stenson BJ, Tarnow-Mordi WO, Darlow BA, Simes J, Juszczak E, Askie L, Battin M, Bowler U, Broadbent R, Cairns P, Davis PG, Deshpande S, Donoghoe M, Doyle L, Fleck BW, Ghadge A, Hague W, Halliday HL, Hewson M, King A, Kirby A, Marlow N, Meyer M, Morley C, Simmer K, Tin W, Wardle SP, Brocklehurst P. Oxygen saturation and outcomes in preterm infants. N Engl J Med. 2013;368:2094–104.CrossRefGoogle Scholar
  88. 88.
    Lloyd J, Askie L, Smith J, Tarnow-Mordi W. Supplemental oxygen for the treatment of prethreshold retinopathy of prematurity. Cochrane database of systematic reviews. 2003;(2):CD003482.Google Scholar
  89. 89.
    Henderson-Smart DJ, Steer PA. Caffeine versus theophylline for apnea in preterm infants. Cochrane Database Syst Rev. 2010;(1):CD000273.Google Scholar
  90. 90.
    Chen ML, Guo L, Smith LE, Dammann CE, Dammann O. High or low oxygen saturation and severe retinopathy of prematurity: a meta-analysis. Pediatrics. 2010;125:e1483–92.PubMedCentralCrossRefPubMedGoogle Scholar
  91. 91.
    Tarnow-Mordi WO, Darlow B, Doyle L. Target ranges of oxygen saturation in extremely preterm infants. N Engl J Med. 2010;363:1285.CrossRefPubMedGoogle Scholar

Copyright information

© Springer International Publishing Switzerland 2016

Authors and Affiliations

  1. 1.Central Clinical School, Discipline of Gynecology, Obstetrics and NeonatologyUniversity of SydneySydneyAustralia
  2. 2.RPA Newborn Care, Royal Prince Alfred HospitalSydneyAustralia

Personalised recommendations